Akcea Therapeutics Inc. (AKCA) NASDAQ/NGS (GLOBAL SELECT MARKET)

$18.17 - (-)

Market Cap: -

As of 10/09/20 12:00 AM EDT. Market closed.

(AKCA)

Akcea Therapeutics Inc. (AKCA)
NASDAQ/NGS (GLOBAL SELECT MARKET)

$18.17
- (-)

Market Cap: -

As of 10/09/20 12:00 AM EDT. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO Compensation (Base)
$500,597
CEO Compensation (Total)
$5.21M
URL
Address
22 Boston Wharf Rd Fl 9, Massachusetts, Boston, 02210-1838.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Damien McDevitt
CEO Compensation (Base)
$500,597
CEO Compensation (Total)
$5.21M
Address
22 Boston Wharf Rd Fl 9, Massachusetts, Boston, 02210-1838.
PRICE CHART FOR AKCEA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$18.17
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
101,598,619
Open
-
Previous Close
$18.17
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
101,598,619
FINANCIAL STATEMENTS FOR AKCEA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AKCEA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
IONIS PHARMACEUTICALS INC10% OwnerOct 10, 2020 Buy$18.1521,237,715385,464,51998,322,397Oct 14, 2020, 04:05 PM
PRICE MICHAEL DENNISChief Financial OfficerOct 12, 2020 Option Exercise$18.1550,000907,5000Oct 13, 2020, 04:04 PM
Patterson Joshua F.General CounselOct 12, 2020 Option Exercise$18.1526,532481,5560Oct 13, 2020, 04:02 PM
Jenne KyleChief Commercial OfficerOct 12, 2020 Option Exercise$18.1552,012944,0180Oct 13, 2020, 03:59 PM
Howarth Alex G.Chief Operating OfficerOct 12, 2020 Option Exercise$18.1566,8001,212,4200Oct 13, 2020, 03:58 PM
Andrews William T.Chief Medical OfficerOct 12, 2020 Option Exercise$18.1537,500680,6250Oct 13, 2020, 03:56 PM
McDevitt DamienChief Executive OfficerOct 12, 2020 Option Exercise$18.15242,9784,410,0510Oct 13, 2020, 03:54 PM
Patterson Joshua F.General CounselSep 22, 2020 Sale$18.123195,78026,532Sep 24, 2020, 04:25 PM
Jenne KyleChief Commercial OfficerSep 22, 2020 Sale$18.1272013,04652,012Sep 24, 2020, 04:21 PM
McDevitt DamienChief Executive OfficerSep 22, 2020 Sale$18.128,709157,807242,978Sep 24, 2020, 04:19 PM
McDevitt DamienChief Executive OfficerAug 31, 2020 Option Exercise$14.401,10415,896251,687Sep 02, 2020, 04:20 PM
Patterson Joshua F.General CounselJul 17, 2020 Sale$12.502633,28826,851Jul 20, 2020, 05:18 PM
Patterson Joshua F.General CounselMar 23, 2020 Sale$11.763353,93814,614Mar 25, 2020, 04:44 PM
Jenne KyleChief Commercial OfficerMar 23, 2020 Sale$11.757799,15352,732Mar 25, 2020, 04:43 PM
O'Dea LouisChief Medical OfficerMar 23, 2020 Sale$11.753,19837,57961,602Mar 25, 2020, 04:42 PM
McDevitt DamienChief Executive OfficerMar 23, 2020 Sale$11.759,417110,649245,783Mar 25, 2020, 04:41 PM
Goldberg Jeff MarcChief Operating OfficerSep 26, 2019 Option Exercise$16.64268,1114,461,367156,631Sep 30, 2019, 09:26 PM
Goldberg Jeff MarcChief Operating OfficerSep 26, 2019 Option Exercise$6.96421,4322,932,747305,560Sep 30, 2019, 09:26 PM
Soteropoulos PaulaChief Executive OfficerSep 26, 2019 Option Exercise$16.641,383,71223,024,967678,149Sep 30, 2019, 05:52 PM
Soteropoulos PaulaChief Executive OfficerSep 26, 2019 Option Exercise$7.052,061,86114,538,2541,711,079Sep 30, 2019, 05:52 PM
Boyce SarahPresidentJul 15, 2019 Sale$23.521,81942,78319,888Jul 17, 2019, 04:52 PM
Boyce SarahPresidentJul 01, 2019 Option Exercise$20.0481316,29521,707Jul 03, 2019, 04:31 PM
Goldberg Jeff MarcChief Operating OfficerJul 01, 2019 Option Exercise$20.044308,6183,310Jul 03, 2019, 04:28 PM
Goldberg Jeff MarcChief Operating OfficerApr 08, 2019 Option Exercise$6.4820,000129,60022,880Apr 09, 2019, 07:00 PM
Goldberg Jeff MarcChief Operating OfficerApr 05, 2019 Option Exercise$6.4830,000194,40032,880Apr 09, 2019, 07:00 PM
Goldberg Jeff MarcChief Operating OfficerApr 05, 2019 Sale$31.7130,000951,3002,880Apr 09, 2019, 07:00 PM
Goldberg Jeff MarcChief Operating OfficerApr 08, 2019 Sale$31.7220,000634,4182,880Apr 09, 2019, 07:00 PM
Soteropoulos PaulaChief Executive OfficerApr 08, 2019 Option Exercise$6.481,78711,5801,787Apr 09, 2019, 06:59 PM
Soteropoulos PaulaChief Executive OfficerApr 05, 2019 Option Exercise$6.4830,000194,40030,000Apr 09, 2019, 06:59 PM
Soteropoulos PaulaChief Executive OfficerApr 08, 2019 Sale$32.171,78757,4800Apr 09, 2019, 06:59 PM
Soteropoulos PaulaChief Executive OfficerApr 05, 2019 Sale$32.1130,000963,3000Apr 09, 2019, 06:59 PM
Soteropoulos PaulaChief Executive OfficerMar 06, 2019 Option Exercise$6.4818,386119,14118,386Mar 07, 2019, 05:20 PM
Soteropoulos PaulaChief Executive OfficerMar 06, 2019 Sale$32.1418,386590,8560Mar 07, 2019, 05:20 PM
Goldberg Jeff MarcChief Operating OfficerJan 01, 2019 Option Exercise$21.5149310,6062,880Jan 04, 2019, 05:33 PM
Goldberg Jeff MarcChief Operating OfficerJul 01, 2018 Option Exercise$14.771,39820,6532,387Jul 02, 2018, 07:10 PM
IONIS PHARMACEUTICALS INC10% OwnerApr 17, 2018 Buy$18.7510,666,666199,999,98864,114,545Apr 19, 2018, 06:48 PM
Goldberg Jeff MarcChief Operating OfficerJan 01, 2018 Option Exercise$6.809896,725989Jan 04, 2018, 07:00 PM
IONIS PHARMACEUTICALS INC10% OwnerJul 19, 2017 Buy$8.003,125,00025,000,00045,447,879Jul 21, 2017, 04:04 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
IONIS PHARMACEUTICALS INC10% Owner10/10/2020385,464,519
PRICE MICHAEL DENNISChief Financial Officer10/12/2020907,500
Patterson Joshua F.General Counsel10/12/2020481,556
Jenne KyleChief Commercial Officer10/12/2020944,018
Howarth Alex G.Chief Operating Officer10/12/20201,212,420
Andrews William T.Chief Medical Officer10/12/2020680,625
McDevitt DamienChief Executive Officer10/12/20204,410,051
Patterson Joshua F.General Counsel09/22/20205,780
Jenne KyleChief Commercial Officer09/22/202013,046
McDevitt DamienChief Executive Officer09/22/2020157,807
McDevitt DamienChief Executive Officer08/31/202015,896
Patterson Joshua F.General Counsel07/17/20203,288
Patterson Joshua F.General Counsel03/23/20203,938
Jenne KyleChief Commercial Officer03/23/20209,153
O'Dea LouisChief Medical Officer03/23/202037,579
McDevitt DamienChief Executive Officer03/23/2020110,649
Goldberg Jeff MarcChief Operating Officer09/26/20194,461,367
Goldberg Jeff MarcChief Operating Officer09/26/20192,932,747
Soteropoulos PaulaChief Executive Officer09/26/201923,024,967
Soteropoulos PaulaChief Executive Officer09/26/201914,538,254
Boyce SarahPresident07/15/201942,783
Boyce SarahPresident07/01/201916,295
Goldberg Jeff MarcChief Operating Officer07/01/20198,618
Goldberg Jeff MarcChief Operating Officer04/08/2019129,600
Goldberg Jeff MarcChief Operating Officer04/05/2019194,400
Goldberg Jeff MarcChief Operating Officer04/05/2019951,300
Goldberg Jeff MarcChief Operating Officer04/08/2019634,418
Soteropoulos PaulaChief Executive Officer04/08/201911,580
Soteropoulos PaulaChief Executive Officer04/05/2019194,400
Soteropoulos PaulaChief Executive Officer04/08/201957,480
Soteropoulos PaulaChief Executive Officer04/05/2019963,300
Soteropoulos PaulaChief Executive Officer03/06/2019119,141
Soteropoulos PaulaChief Executive Officer03/06/2019590,856
Goldberg Jeff MarcChief Operating Officer01/01/201910,606
Goldberg Jeff MarcChief Operating Officer07/01/201820,653
IONIS PHARMACEUTICALS INC10% Owner04/17/2018199,999,988
Goldberg Jeff MarcChief Operating Officer01/01/20186,725
IONIS PHARMACEUTICALS INC10% Owner07/19/201725,000,000
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR AKCEA THERAPEUTICS INC
LOADING...